Form D · Biotechnology
NEXGEN FORENSIC SCIENCES, INC.
Columbia, MD · CIK 0001757348
Offering snapshot reported Mar 24, 2023 · SEC filing
- Reported sold
- $450K Offering amount: $750K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Dec 18, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 24, 2023 | Initial | $450,319 | No comparison | 9 | SEC filing |
| Nov 6, 2018 | Amendment | $320,970 | $55,000vs Oct 31, 2018 | 6 | SEC filing |
| Oct 31, 2018 | Initial | $265,970 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-476871
Source: Form D, filed Mar 24, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Feldman | Director, Executive, Promoter |
| Joely Gardner | Director |
| Jeffrey Lin | Executive |
| Peter Mc Kenney | Executive |
| David Weitz | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10241 Bradley Lane
Columbia, MD, 21044
Columbia, MD, 21044